Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies

Cleve Clin J Med. 2003 Jul;70(7):624-6, 628-31. doi: 10.3949/ccjm.70.7.624.

Abstract

Amiodarone causes thyrotoxicosis in 3% of US patients who use it. Two types of amiodarone-induced thyrotoxicosis are recognized, designated type 1 and type 2, based on whether or not the patient had a preexisting thyroid disorder. Distinguishing between the two can be difficult, but it is important for providing appropriate therapy promptly.

Publication types

  • Review

MeSH terms

  • Amiodarone / adverse effects*
  • Amiodarone / chemistry
  • Anti-Arrhythmia Agents / adverse effects*
  • Antithyroid Agents / therapeutic use
  • Humans
  • Iodine / adverse effects
  • Practice Guidelines as Topic
  • Thyroidectomy
  • Thyrotoxicosis / chemically induced*
  • Thyrotoxicosis / diagnosis
  • Thyrotoxicosis / therapy

Substances

  • Anti-Arrhythmia Agents
  • Antithyroid Agents
  • Iodine
  • Amiodarone